Heron Therapeuti (HRTX) — Cash Flow Quality Index

Latest as of March 2025: -3.37x

Heron Therapeuti (HRTX) has a Cash Flow Quality Index of -3.37x as of March 2025. Operating cash flow of $-8.87 Million is below net income of $2.63 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore HRTX operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-3.37x
Operating CF / Net Income

Operating Cash Flow

$-8.87 Million
USD

Net Income

$2.63 Million
USD

Data as of

Mar 2025
Most recent filing

Heron Therapeuti Cash Flow Quality Index (1998–2011)

Historical Cash Flow Quality Index for Heron Therapeuti across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see HRTX cash flow conversion.

Annual Cash Flow Quality Index for Heron Therapeuti (1998–2011)

Year-by-year earnings quality comparison for Heron Therapeuti.

Year Quality Index Operating CF (USD) Net Income YoY Change
2011 -20.37x $-7.72 Million $379.00K ▼ -1268.5%
2006 1.74x $9.18 Million $5.27 Million ▲ +578.5%
2000 -0.36x $-3.12 Million $8.55 Million ▼ -45.7%
1999 -0.25x $-600.00K $2.40 Million ▲ +68.3%
1998 -0.79x $-1.50 Million $1.90 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.